Pharmacists in Harrah, OK Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Mr. Donald Brandt Casey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2060 North Church Ave, Harrah, OK 73045 Phone: 405-454-2476 Fax: 405-454-3507 |
 Dr. Hailey D Burch, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19671 Ne 23rd St, Harrah, OK 73045 Phone: 405-454-6261 Fax: 405-454-6262 |
Mr. Stephen Wade Ford, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19655 Ne 23rd St, Harrah, OK 73045 Phone: 405-454-6261 Fax: 405-454-6262 |
Alyssa Elaine Casey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2060 N Church Ave, Harrah, OK 73045 Phone: 405-454-2476 Fax: 405-454-3507 |
Amos Malone, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2060 N Church Ave, Harrah, OK 73045 Phone: 405-454-2477 Fax: 405-454-3507 |
Mr. Raymond Neale Coy Jr., D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19655 Ne 23rd St, Harrah, OK 73045 Phone: 405-454-6261 Fax: 405-454-6262 |
News Archive
New intervention combines social media with behavioral psychology to encourage more HIV testing
Social media such as Twitter and Facebook can be valuable in the fight against HIV in the United States, where research has demonstrated they can prompt high-risk populations to request at-home testing kits for the virus that causes AIDS, suggesting a way to potentially boost testing rates.
UTMB's international vaccine symposium to be held Feb. 7-9
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells
VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.
NovoStent completes enrollment for its SAMBA Stent and Delivery System trial
NovoStent Corporation, a privately held medical device company, today announced the completion of enrollment earlier this summer in the company's European clinical trial evaluating the use of its SAMBATM Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease.
› Verified 5 days ago